Pacific Kids DASH for Health (PacDASH) Randomized, Controlled Trial with DASH Eating Plan Plus Physical Activity Improves Fruit and Vegetable Intake and Diastolic Blood Pressure in Children

Novotny, Rachel; Nigg, Claudio R.; Li, Fenfang; Wilkens, Lynne R. (2015). Pacific Kids DASH for Health (PacDASH) Randomized, Controlled Trial with DASH Eating Plan Plus Physical Activity Improves Fruit and Vegetable Intake and Diastolic Blood Pressure in Children. Childhood obesity, 11(2), pp. 177-186. Mary Ann Liebert 10.1089/chi.2014.0141

Text novotny-et-al-2015-pacific-kids-dash-for-health-_pacdash_-randomized-controlled-trial-with-dash-eating-plan-plus.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (436kB)

Background: Pacific Kids DASH for Health (PacDASH) aimed to improve child diet and physical activity (PA) level and prevent excess weight gain and elevation in blood pressure (BP) at 9 months.
Methods: PacDASH was a two-arm, randomized, controlled trial (ClinicalTrials.gov: NCT00905411). Eighty-five 5- to 8-year-olds in the 50th–99th percentile for BMI were randomly assigned to treatment (n=41) or control (n=44) groups; 62 completed the 9-month trial. Sixty-two percent were female. Mean age was 7.1±0.95 years. Race/ethnicity was Asian (44%), Native Hawaiian or Other Pacific Islander (28%), white (21%), or other race/ethnicity (7%). Intervention was provided at baseline and 3, 6 and 9 months, with monthly supportive mailings between intervention visits, and a follow-up visit at 15 months to observe maintenance. Diet and PA were assessed by 2-day log. Body size, composition, and BP were measured. The intervention effect on diet and PA, body size and composition, and BP by the end of the intervention was tested using an F test from a mixed regression model, after adjustment for sex, age, and ethnic group.
Results: Fruit and vegetable (FV) intake decreased less in the treatment than control group (p=0.04). Diastolic BP (DBP) was 12 percentile units lower in the treatment than control group after 9 months of intervention (p=0.01). There were no group differences in systolic BP (SBP) or body size/composition.
Conclusions: The PacDASH trial enhanced FV intake and DBP, but not SBP or body size/composition.

Interest & Impact

Downloads

1 since deposited on 17 Apr 2024
1 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item